Endocrine-responsive breast cancer and strategies for combating resistance.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12635173.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Deaths from breast cancer have fallen markedly over the past decade due, in part, to the use of endocrine agents that reduce the levels of circulating oestrogens or compete with oestrogen for binding to its receptor. However, many breast tumours either fail to respond or become resistant to endocrine therapies. By understanding the mechanisms that underlie this resistance, we might be able to develop strategies for overcoming or bypassing it.
Medical subject headings
- Breast Neoplasms
- Drug Resistance, Neoplasm
- Estrogens
- Receptors, Estrogen